CytomX Therapeutics to Announce Second Quarter 2020 Financial Results

by NASDAQ Market News July 28, 2020

NASDAQ Market News
Click here to email author

Broward Health Medical Center Becomes First Clinical Site in U.S. for Phase II Trial for LSALT Peptide

Black Diamond Therapeutics Granted Fast Track Designation by the FDA for BDTX-189 for the Treatment of Adult Patients with a Solid Tumor Harboring an Allosteric HER2 Mutation or an EGFR or HER2 Exon 20 Insertion Mutation

Ads